Cancer News
Discover the latest advancements in prevention, early detection, research, treatment, products and services for those affected by cancer and involved in treatment. This section includes organizations raising awareness and funds for cancer research, companies developing technology and medications for cancer treatment and legal and public policy announcements related to carcinogens and cancer care.
Tactiva Therapeutics Reports Data Highlighting a Novel Dual CD4/CD8 T Cell Receptor with Potential for Use Against a Broad Range of Cancers
Tactiva Therapeutics today reported on its unique, dual enhanced adoptive cell therapy (DEACT) platform, incorporating its proprietary, engineered CD4/CD8 T cell receptors (TCR) with potential broad utility in cancer immunotherapy, including melanoma and ovarian cancer. A late breaking abstract... - April 05, 2017 - Tactiva Therapeutics
Global Kidney Cancer Drugs Market by Branded Drugs, Clinical Pipeline, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.
Kidney Cancer Drugs Market by Branded Drug Type – Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient (Pazopanib), Clinical Phase 1, 2 and 3 Drugs (AGS-003, Cabozantinib, Dovitinib, Keytruda, Opdivo) Pipeline Analysis 2016-2020 - March 23, 2017 - iHealthcareAnalyst, Inc.
Alfa Scientific Designs, Inc., Pledges to Reach 80% Screened for Colorectal Cancer
Company joins the National Colorectal Cancer Roundtable to meet goal by 2018. - March 21, 2017 - Alfa Scientific Designs
Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee
Dr. Maker brings surgical oncology experience with expertise in liver, gallbladder. colon, pancreatic, and other cancers to Jivana Biotechnology's advisory committee. - March 16, 2017 - Jivana Biotechnology Inc
Great Futures Celebrity Charity Polo: The Chauncey F. Lufkin III Foundation Was a Proud Sponsor of the 4th Annual Benefit for the Neil S. Hirsch Family Boys & Girls Club
Chauncey Lufkin, local philanthropist, supports several Palm Beach County charitable organizations throughout the year, including The Boys and Girls Club and Quantum House. - March 14, 2017 - The Chauncey F. Lufkin III Foundation
Algae Dynamics Corp Announces Research Agreement with University of Western Ontario
Algae Dynamics Corp, today announced a research and product development agreement with Western University to perform research on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia. This is the second of the recently announced research agreements with Canadian universities involving cannabis oil research. This announcement brings Algae Dynamics total university research contributions to $1. 6 Million for both programs. - March 13, 2017 - Algae Dynamics Corp
Innovation Has Finally Come to Healthcare Recruitment
With their new premier healthcare job board, eLinkXchange hopes to change the recruitment industry for employers and job seekers. - March 13, 2017 - eLink Xchange
Global In Vitro Colorectal Cancer Testing Market by Test Types, Product Pipeline and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.
In Vitro Colorectal Cancer Testing Market by Test Types (Fecal Occult Blood Tests, Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test, Stool Biomarkers Tests , Cologuard, M2-PK Stool Test, Blood Biomarker Tests, ColoSentry, ColoVantage, Epi proColon, mS9), and Product Pipeline (Cologic, Colox, MarCarePlex, MeScore CRC, miRSIGN, PanC – Dx) 2016-2020 - March 11, 2017 - iHealthcareAnalyst, Inc.
New Study Links Weed-Killer Glyphosate with Autism
A new study has been published in a peer-reviewed journal about the links between the weed-killer glyphosate (RoundUpTM) and autism. The World Health Organization International Agency for Research on Cancer published a summary in March 2015 that classified glyphosate as a probable carcinogen in humans. - March 07, 2017 - The Great Plains Laboratory, Inc.
Moving Pathology Information with VoiceOver at the 2017 Annual Meeting of the United States and Canada Academy of Pathology
Voicebrook will be showcasing its fast and accurate Pathology reporting solution at the USCAP Annual Meeting in San Antonio. - March 04, 2017 - Voicebrook, Inc.
PTSD Treatments Can Cost Up to $7,000 a Year, But a Group of NET-Trained Practitioners Treated Patients Effectively and Quickly for a Fraction of the Cost
People often experience symptoms of PTSD such as anxiety, stress, and fear from traumatic life events. Physician researchers (funded by the ONE Research Foundation) conducted a study on Neuro Emotional Technique (NET), a mind-body therapy, at The Marcus Institute of Integrative Health at Thomas... - February 28, 2017 - ONE Research Foundation
Gilad&Gilad Gambles on Las Vegas
Gilad&Gilad, the health science company is presently relocating its headquarters to Henderson (a suburb of Las Vegas), Nevada, expecting growth of its dietary supplements products, AgmaSet® and AgmaVet(TM), for nerve health. - February 28, 2017 - Gilad&Gilad
Global Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography and Forecast to 2020, Published by iHealthcareAnalyst Inc.
Drug Eluting Beads, Microcatheters and Radiopaque Beads in Interventional Oncology Market by Geography North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World and Forecast 2016-2020. - February 27, 2017 - iHealthcareAnalyst, Inc.
Global Embolization in Interventional Oncology Market Analysis: Procedures, Growth Trends and Forecast to 2020, New Report by iHealthcareAnalyst, Inc.
Embolization in Interventional Oncology Market by Procedure Type (Bland Embolization, Radioembolization, Transarterial Chemoembolization) and Forecast 2016-2020. - February 25, 2017 - iHealthcareAnalyst, Inc.
Strathmore’s Who’s Who Honors Susan J. Littman, M.D. as Professional of the Year
Susan J. Littman, of Maple Glen, Pennsylvania, was recognized as a 2017 Professional of the Year by Strathmore’s Who’s Who for her outstanding contributions and achievements in the field of Oncology. - February 24, 2017 - Strathmore Who's Who
The 2017 Women in Oncology Award Winners Honored by PRIMO Education
The winners of the 2017 Women in Oncology Award were announced this morning at the 2nd Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting. The Women in Oncology Awards are presented annually to three outstanding women in academia, industry, and advocacy, and seeks to recognize women who have made outstanding contributions to the lives of those fighting cancer. - February 13, 2017 - Cancer Expert Now, Inc.
Good News! Local Independent Oncology Clinic Recognized for Quality Laboratory Services
Personalized Hematology-Oncology of Wake Forest, PLLC – an independent oncology clinic in Wake Forest, NC – has met all criteria for Laboratory Accreditation by COLA, a national healthcare accreditation organization. Accreditation is given only to laboratories that apply rigid standards... - February 07, 2017 - Personalized Hematology-Oncology of Wake Forest, PLLC
Global Companion Diagnostics Market Analysis: Indications, Growth Trends and Forecast to 2020, New Research by iHealthcareAnalyst, Inc.
Companion Diagnostics Market by Indication or Disease Type (Breast Cancer, Colorectal Cancer, Gastric Cancer, Lung Cancer, Melanoma) 2016-2020 - February 02, 2017 - iHealthcareAnalyst, Inc.
Global Circulating Tumor Cells Prognostic Technologies Market Analysis: Technologies, Applications and Forecast to 2020, New Research Study by iHealthcareAnalyst, Inc.
Circulating Tumor Cells Prognostic Technologies Market by Technology (Tumor Cell Enrichment, Centrifugation, Filtration, Immunological Methods, Tumor Cell Detection, Molecular Methods, Optical Methods), and Application (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Ovarian Cancer and Pancreatic Cancer) 2016-2020 - January 27, 2017 - iHealthcareAnalyst, Inc.
Global Cervical Cancer Diagnostic Testing Market Analysis: Test Types, Growth Trends and Forecast to 2020, New Research Published by iHealthcareAnalyst, Inc.
Cervical Cancer Diagnostic Testing Market by Test Type (Cervical Biopsy, Colposcopy, Endocervical Curettage, HPV Typing, Loop electrosurgical procedure, Pap Smear Testing), and Imaging Tests for Stage Detection (Computed tomography or CAT, Magnetic resonance imaging, Positron emission tomography, Chest X-Ray) 2016-2020 - January 27, 2017 - iHealthcareAnalyst, Inc.
Military Combat Veteran Serves Again in the Fight Against Breast Cancer After Losing Mom
A Night of Fashion is an incredible charity event held at the exquisite Callanwolde Fine Arts Center on Thursday, April 6, 2017 from 7:00pm to 9:30pm to support the programs of I Will Survive, Inc. Save the date by getting tickets today. - January 26, 2017 - I Will Survive, Inc.
Global Cancer Diagnostics Market Analysis: Diagnostics Methods, Applications and Forecast to 2020, Reports iHealthcareAnalyst, Inc.
Cancer Diagnostics Market by Diagnostic Method such as Biopsy Test (Bone Marrow, Endoscopic, Needle Biopsy), Endoscopy Test (Bronchoscopy, Colonoscopy, Colposcopy, Sigmoidoscopy), Diagnostic Imaging (CT, MRI, PET, Mammography, Ultrasound), and Detection of Cancer-Specific Tumor Biomarkers, and by Application (Organ or Cell-Specific Cancer Types such as Blood, Breast, Colorectal, Kidney, Liver, Lung, Ovarian, Pancreatic, Prostate Cancer) 2016-2020. - January 20, 2017 - iHealthcareAnalyst, Inc.
New Study Derives Prostate Cancer Heat Map & Analysis Along with Clinical Benchmarks for Therapies During 2016-2022
Report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. - January 20, 2017 - Market Research Hub
Big Pharma Perspective on Adaptive Clinical Trial Designs
Boehringer-Ingelheim, Grünenthal and AstraZeneca to discuss company approach to applied clinical trials. - January 19, 2017 - SAE Media Group
G&L Scientific Inc. Announces Opening of New Offices in Cambridge, Massachusetts
G&L Scientific Inc, the leading provider of clinical and scientific consulting and resource to the healthcare industry (http://www.gandlscientific.com), has announced the opening of new offices in Cambridge, Massachusetts, strengthening and improving access to its expanding team of clinical and scientific consultants and contractors. This is the latest step in G&L’s expansion of its global clinical consulting services throughout the United States. - January 19, 2017 - G&L Scientific Inc
New Radiotherapy Center in Ebersberg Partners with humediQ to Enhance Patient Safety and Efficiency
On December 12th, 2016, a new radiotherapy center has opened its doors in Ebersberg, Germany. The center is working closely with humediQ in offering the highest standard of patient safety during cancer treatment. Radiotherapy center Ebersberg is a representative office of the renowned clinic in... - January 11, 2017 - HUMEDIQ global GmbH
Radon Exposure is Leading Cause of Lung Cancer Among Non-Smokers
January is National Radon Action Month and Waukesha County health officials are encouraging homeowners to check their home's radon levels. Exposure to radioactive radon gas is the leading cause of lung cancer among non-smokers nationwide. “Radon is an easily mitigated heath risk. The small... - January 05, 2017 - Waukesha County Recycling
Leah A. Rivera Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication
Leah A. Rivera of Duarte, California has been recognized as a Professional of the Year for 2016 by Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements for almost 20 years in the field of healthcare. About Leah A. Rivera Ms. Rivera is the Lead... - December 21, 2016 - Strathmore Worldwide
Bioprognos Obtains the CE Marking for Its Algorithm to Support the Diagnostic of Lung Cancer
Bioprognos obtains the CE Declaration of Conformity for its algorithm to support the diagnostic of lung cancer after complying with the requirements of the European directive on medical devices and implementing a quality management system according to the standard UNE-EN ISO 13485:2016. - December 19, 2016 - Bioprognos SL
Phi Life Sciences Launches Licensed Prostate Mitomic Test (PMT™) for Prostate Cancer Risk
Phi Life Sciences (Phi), a molecular diagnostic and laboratory service company that empowers physicians to deliver precision treatments and diagnostics to improve patient care and health, announced today that it has launched the Prostate Mitomic Test (PMT™) that is licensed from MDNA Life... - December 19, 2016 - Phi Life Sciences
Susan J. Littman, M.D. Honored as a Strathmore’s Who’s Who Lifetime VIP Member
Susan J. Littman, of Maple Glen, Pennsylvania, has been recognized as a Lifetime VIP Member by Strathmore’s Who’s Who for her outstanding contributions and achievements in the field of Oncology. - December 17, 2016 - Strathmore Who's Who
Fierce Innovation Awards: Life Sciences Edition Announce Finalists, Innovative Biochips Recognized
Innovative Biochips LLC has been selected as a finalist in Fierce Innovation Awards 2016 for its innovative product, Automated Yeast Aging Analysis System. - December 15, 2016 - Innovative Biochips
New Study Explores Market Pipeline Analysis of Salivary Gland Cancer in H2 2016
The report provides comprehensive information on the therapeutics under development for Salivary Gland Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. - December 04, 2016 - Market Research Hub
Acute Lymphocytic Leukemia Drug Pipeline Analysis and Therapeutic Assessment, H2 2016
Report Provides provides broad information on the therapeutics under development for Acute Lymphocytic Leukemia (Oncology), with the complete analysis by stage of development, drug target, route of administration (RoA), mechanism of action (MoA) and molecule type. - November 30, 2016 - Market Research Hub
A Rare Transition of Non-Hodgkin Lymphoma Into Classical Hodgkin Disease Reported in PiscoMed's Journal AMOR
Researchers document first reported case of an intermediate stage of lymphoma transformation - November 26, 2016 - PiscoMed Publishing Pte Ltd
Global Cancer Technology, Inc. Signs Licensing Agreement with the University of California San Diego
Announcing an agreement to purchase patent and IP technology from UCSD for a novel way to track medical instruments using Nano Quantum Dots - November 25, 2016 - Global Cancer Technology, Inc
The Children's Security Blanket to Ensure Families of Children Battling Cancer Experience More Joy and Less Worry for the Holidays
Anonymous donors enable nonprofit to provide an early Christmas for many families. - November 14, 2016 - Children's Security Blanket
South Nassau Communities Hospital Surgeon Named to "America's Best Physicians"
The NCAB is a private research organization dedicated to providing consumers information about the finest professionals across the nation. - November 06, 2016 - Mount Sinai South Nassau
The Gateway Family YMCA Offers LIVESTRONG® at the YMCA
A physical activity and well-being intitative for cancer survivors. - November 01, 2016 - The Gateway Family YMCA
Mary’s Center Receives Grant from the American Cancer Society and the National Football League to Fight Breast Cancer in Washington DC
The American Cancer Society and NFL have awarded Mary’s Center a grant to provide breast cancer education, outreach and navigation, and help individuals access screenings in Washington, DC. - October 21, 2016 - Mary's Center
Nerviano Medical Sciences Presents Data Regarding a Potent New Cytotoxic Molecule for ADC Generation
NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, hbighly suited to conjugation with targeted antibodies. - October 20, 2016 - NMS Group
NAPBC Accredits South Nassau Communities Hospital's Center for Breast Health
To achieve the re-accreditation, South Nassau demonstrated its compliance with standards established by the NAPBC to provide the best possible care to patients with diseases of the breast. - October 19, 2016 - Mount Sinai South Nassau
Gastric Cancer Foundation Event Promotes Research Funding to Improve Treatments and Save Lives - "A Cause for Hope" on November 18 in the San Francisco Bay Area
Stomach Cancer is the third leading cause of cancer deaths in the world, and is increasingly affecting young people. Yet only a tiny fraction of the nearly 1M gastric cancer sufferers worldwide have well-defined tumor mutations that can be addressed with current treatment options. To increase funding for the disease and encourage more researchers to focus on stomach cancer treatment, the Gastric Cancer Foundation will hold its Annual Event, A Cause for Hope, November 18 in the SF Bay Area. - October 17, 2016 - Gastric Cancer Foundation
FlexPrint Hosts Annual Golf Tournament to Support Children Touched by a Parent's Cancer
National Managed Print Provider Hosts 11th Annual Golf Invitational Benefiting Camp Kesem. - October 16, 2016 - Flex Technology Group
Details on Shocking Fundraiser for Children with Cancer
Company Raises Thousands for 3, 11 and 13-Year-Old’s While Playing Golf - October 14, 2016 - Residential Home Funding Corp.
Proton Partners International and humediQ GmbH Partner to Deliver Safe Radiotherapy
Proton Partners International has partnered with humediQ GmbH to achieve its goal of creating centres of excellence for advanced cancer treatment in the UK and beyond by providing the latest, most advanced technology in radiotherapy patient monitoring. Proton Partners International will operate... - October 03, 2016 - HUMEDIQ global GmbH
Tigerlily Foundation President and Breast Cancer Advocate, Maimah Karmo, Featured by Oprah Winfrey on OWN TV
Tigerlily Foundation is excited that its President and Breast Cancer Advocate, Maimah Karmo, was featured by Oprah Winfrey on OWN TV's "Where Are They Now," highlighting the organization's work supporting young women - before, during and after breast cancer. - October 01, 2016 - Tigerlily Foundation
New Breast Cancer Knowledge Centre Launches on epgonline.org, the Website for Healthcare Professionals
A new clinical resource has launched on epgonline.org this week. The Breast Cancer Knowledge Centre is intended for oncologists and other healthcare professionals involved in the treatment and care of patients with this condition. Breast cancer is the second most common cancer worldwide. It has... - October 01, 2016 - EPG Health Media
Children with High Grade Brain Tumors Will Soon be Able to Receive Cutting Edge Oncolytic Virus Therapy
Re-engineered Polio Virus with Dramatic Response in Adults to be Made Available to Children in a Phase 1 Clinical Trial Jointly Funded by The Andrew McDonough B+ Foundation and Solving Kids’ Cancer. - September 30, 2016 - Solving Kids' Cancer
Aspiria Partners with Gilda’s Club Simcoe Muskoka to Bring You OnCallogic
Mental health assistance provider Aspiria Corp. has partnered with Gilda's Club Simcoe Muskoka to launch OnCallogic, a service designed to educate and support employees dealing with cancer in the workplace. - September 30, 2016 - Aspiria Corp.